Related Experiment Video
Updated: Aug 15, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection
Jan Holgersson1, Anki Gustafsson, Michael E Breimer
1Division of Clinical Immunology, Karolinska Institute, Karolinska University Hospital at Huddinge, Stockholm, Sweden.
Abstract:
The relative shortage of human organs for transplantation is today the major barrier to a broader use of transplantation as a means of treating patients with end-stage organ failure. This barrier could be partly overcome by an increased use of blood group ABO-incompatible live donors, and such trials are currently underway at several transplant centres. If xenotransplantation can be used clinically in the future, the human organ shortage will, in principle, be eradicated. In both these cases, carbohydrate antigens and the corresponding anti-carbohydrate antibodies are the major primary immunological barriers to overcome. Refined carbohydrate-based therapeutics may permit an increased number of ABO-incompatible transplantations to be carried out, and may remove the initial barriers to clinical xenotransplantation. Here, we will discuss the chemical characteristics of protein-carbohydrate interactions and outline carbohydrate-based antirejection therapies as used today in experimental as well as in clinical settings. Novel mucin-based adsorbers of natural anti-carbohydrate antibodies will also be described.
Insights
Carbohydrate-based therapeutics show promise for overcoming immune barriers in organ transplantation, potentially increasing the use of ABO-incompatible donors and enabling future xenotransplantation. These therapies target critical carbohydrate antigens and antibodies involved in transplant rejection.
Area of Science:
- Immunology
- Transplantation Medicine
- Carbohydrate Chemistry
Background:
- The critical shortage of human organs for transplantation limits treatment options for end-stage organ failure.
- Blood group ABO-incompatible live donors and xenotransplantation are potential solutions but face significant immunological barriers.
- Carbohydrate antigens and anti-carbohydrate antibodies represent primary obstacles in both ABO-incompatible transplantation and xenotransplantation.
Purpose of the Study:
- To explore the role of carbohydrate antigens and antibodies in transplantation immunology.
- To discuss the chemical characteristics of protein-carbohydrate interactions relevant to transplantation.
- To review current and experimental carbohydrate-based antirejection therapies and novel antibody adsorber technologies.
Main Methods:
- Discussion of chemical properties of protein-carbohydrate interactions.
- Review of experimental and clinical data on carbohydrate-based antirejection therapies.
- Description of novel mucin-based adsorbers for natural anti-carbohydrate antibodies.
Main Results:
- Carbohydrate-based therapeutics offer a strategy to mitigate immune responses against transplanted organs.
- Refined carbohydrate therapeutics may facilitate more ABO-incompatible transplantations.
- These approaches may address initial immunological hurdles for clinical xenotransplantation.
Conclusions:
- Carbohydrate-based strategies are crucial for advancing transplantation medicine by overcoming immune incompatibilities.
- Further development of carbohydrate therapeutics and antibody adsorbers is essential for broader clinical application.
- These innovations hold the potential to significantly alleviate the organ shortage crisis.
More Related Videos
08:49Printed Glycan Array: A Sensitive Technique for the Analysis of the Repertoire of Circulating Anti-carbohydrate Antibodies in Small Animals
Published on: February 14, 2019
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Related Concept Videos
Protein-protein Interfaces
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Membrane Carbohydrates
Membrane carbohydrates do not have any hydrophobic region and are exclusively located on the cell's outer surface. The addition of sugar molecules or glycosylation of proteins happens in...
Tumor Immunotherapy
Inhibitors of Viral Protein Synthesis